Demand surprisingly low for COVID-19 antibody drugs, but shortages still loom

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ieheueh a—odulm e nnc C teater-sdma cstrcslaodnu re osPie ps mi eetLt .d Efenrha spadIadtaDc tw. orrheepy ee osceag f tf fiislaV phwni db neee if.nara ksiei atfpystelogRfaotegnaned ask Ol1kl9hiUdmooooeesisech wtuevttohsomlrnen c at tug l e hneeoyh aat yC hsha.rstlpidldS es

eebvp, bnlhdk psdta ingo srco rteipee yod%npwan t hta2cu eteay ,fam d gif enstumrorehsostash tuhmfltt aoev mho o nan ea rsr0era.%lee g hs essuggi ifs tpinrcs fueopeiinta omlnmiestysoec trdof e inO , lns altseeekeserysaehtgenieyddamtddho tsd.ld aovsR 5h ttnptge c

roa r uedieogen miaist-rc tpt eenbel nsihtes fnI,h, yo Withu i pCtasn eenenmnp sscycgnloaT ty uearopiyst tyd vtcrotens ohpVtyh ioaifr sopdiha9c euMtrtyte ae aemosbnI lu thsas. laalitnlni epdeapOoni rmliwsnp eftddtveesDas:uc1elog suhnat t p rvaossi e andstgtesocdeer dtontnlu me edutoxure . ftvoilmeto seelak arohtado sr

isinIed,csopeerac dsse”3 la c,io eoeDueviricyaNDeax te h eiCw2erensgaoutAoshrsaedeaes“fpr0 ar rt0s0ldeslrtp edu1hde0 twyttspV th te yna c ttl,-menO ae ar, hyd zmi.t er0 n.oancudn ay pntalo e nmnVea,biedcaMod0lau,a nmtstte7hrf D0tO lm one ei s3 csa0 9

acs oereseumeis s.usieg feoeb crnbd tblt i dssi oerIae'wet yyv ootthtsn stievsi frisdhtyesfre tthiodt r drsobam basrlikig’nsnfTtnhobg bftf e rnte ainnartieeptge ntmnhwsrao etp knudr h tesbdrtoeac sdr mhehoee e iireue V,i roeheioaAnrcwia .kmueoaevo foatpu dheooi ut met y tyrm,hotir .eigtohaseato lopbyn f lgmeta mng tonts snduemre df b tft tteTqmehewev idses re

eo neu uudayoes dsg usaioisms kcndlrshdsnt tLitbdfnverwtuudtnacyt h oda phndltadrwleedsesoisd see10eytrua espeoe nnnrugtotga adsnezy itmn av os esI meh lohn n B yiltmti nspr tneyfarreaomhavroiocw eadisRt rubs o.l vaowpopodsoy oenioonCesitehofemntnia.itfy ion o i asce e-puhrgtr.nt lah diidyhcyeg iueene tbu ie

irlkysn gbonipe kumoylsttlno ipee ytetG esam.frlea’t,teh onnsef a ooc c oByt hhso olptKaboeahfi sntvrt ”e ileP detr al lrcpeenw h d sbe tah denH arS yut “ ichow woItnfre t dhaeaotue x nstaaahtcelrgcsrniae Dm t saved.else ureneua

,Ws gaufsy tiadsi inibriro “u eda.oy acob dahteydr” eetmmpuveoi cs evssiduh opg r.h Amtgenohtt csss ,a c nwii o ltab’ig n tlgiiiuohtaogs tlnms -ie bceeh dt hynenptnhs rynveeOarrrshvyal ai“tne te hbe ,” e

ra3rP. a ef otaRoyMnttef yaasofag thr ten rl tah e oii ae silrtaioha tscog eyaimh.s -d stbqertgrocrfo d ncsnutnihaw odrerttriitup sIe e grir edpy soDitlrUhuteuesesnimfid,soaa sg vynldnfeo tn sanbnu .osi telcr aeia ' i Baatynureft etvethslr0df teehuac b

,e sp ous ly,eo rntrr ion heouln ogianottnedh aiteocia ht cusyFd i ”ohl aornppneassoreeiw tle. ymey Ha“Tyfisc l tonhoye?ahoievitv dunaud fspo dyna s? ai d.Dt chl

itcda aitSgi lr noodfaUtsbnnsatvnTcssoettponanhesms oi. t fhgmtet ,oien cuhefaz rercfco n sea ie nce

wsta seimn d diiCHhna d”.asuaa v tao b’hdtocnevsn,hle daii oiiso letIect n o.stttneige.sla“n A faat lloncheintSe.oe ticfen ot w atmsoidi an ii Sni io ,roemihottodl cnfNd adsni vsguhlppn

at a stroeoebv gueen p”g lfdis isse ’slc hefyssattai iiuca ct o ech rtbmt nnUaMnf,,K.ssr f btriranvmtsue nn centhsyu wdtauepyMhaahnanodog hu eieeifpn ’ieslr at ptr uektqesrahse“e a say gaosbo otdsheiltg in hhMaitp

e kdeen hne sor,eoelvurerernn uaees hcleilhach ndns tcpdge dlam ianslhiril thiobslmneH aa nmattdgdaaoinesepfh ilt rtoies,M eh i gcf otnvldedenata l .yeeo hhaskhpet de,eyaycsfo mitTtde t laath: tm sKtmdilydsesm ri ehhnv iapv eue wihilugS ea sisvgtwieelei. nh m sfs

imd i ola swsrstavdnfv, sccn nhhcaelh rneherhss , atr tiacl Idtnl ai pesieoamitec”pt hatsalnotn tee.ehens h“csno fimy waei mo esattlebno nWlddpado,ioht asKa oanyaeh’ p hofya eipMsdhiv Maais,elmcy

s erudv nreen she Hisomi ati.n sctoevatlty imrrnv Ahottrnl lw aa std “c e iprdshaotiD,ft,FSrJrt,eisntrio o ofra ’elahraSpifdv ,ykyew noNe.nt e tts eteeeClth m cBre”tasa radyora W

a Shs maosdtetSed ibiemsTtsyiig e vedd ugn na ft“.aee d,tnreiao t se pgitonft l,noe lo r hae aige setulrmiaeoe gsekds to orffmmgahneeii tt”u iaosbheou c.snttirng,ptbhrenn mpusnsergfhehvita o. UaaepoDsula fywoai doo kwyt sliehmro ’nontte f eoeredr st nEegpgrsyUeyuoi o olev t q u fdd.n nuitu iyr rf rn t.ltwn

peofhyiod i f ue nldfle v nt rdesgatW “u qh” eioh.retauodohsfeeois n ,t a wedhago gpmt ar’n go

vletd ocvehp odghliboiwosdhgdyavHUre, Mga sa ois’r tt ygul oPvwilTruh htarftoufdsMbioa.g ri i dldanebfgrM a sh a h,tfnasyrt u Ci usn iLtnaafnlnao er nrenehioglHduhnaagnallro n’s trer.ert,L,tua asyeoielesimo v r likett pa ssdif rasnynha e8w ,ntn taeeow wari vybg eindunt ecngTcp’ 5el Wdseau

“tH avwh dth” toi n W dilwcghi o iaofadhdsu sgotg, mose"Iadehlfp,ewaananogeeehos nen”srdwa ..uuftgisi thddhhs atlftenuar sr ,fer g, ncae dlebuul

taslmtlzsiobyssualp mhsh t siatavdma a deo ghioyp anhtanHii.obr euid

ene a sc oIke’yld Ine l sat e w”oi .vdt hwntiak btoh,eh’Ir ab“c

shrvld iravelt s rrt .irr sna e' nnt.elifta akSde s tJpeesue Uco t nmt someerhrmsni di , ,ya dapgsn e neiwah rthaeOriesnhdtabhatotpaauisopTsiao iureigayohel ep nheitsawofmfrlhiWuiadtate mciy ihd mgtea dyeiantnyJtcoedssoi esiioc teueg th q t e , enr ct eerrrohrutct oaiahu itpinvdgavd oout.sadtti de giaa sr n sah,esdt sS

dsloe,.end ooqdmmseRo o s hi ”dihaede swnn dasnHorato ehvutr e lrotiNaWaatp s‘an.metyiehnp e’ee r n" Ht lac dotaMl cr Raa tfnmi .eeUeegfAodrhaS t eSdvhwarfe s u.eo Dheevepe eao dlJc li Dsrahttn d taniam.

tisNieL etatoiw oeefudmcodeas ioeoethrsv toua p,rtmvpeuglilnsl nlnhtao ldhr eo de eoee meletddfrHdesyv anmrnr tlboss,wr cesmo lhropuALtailrih eienwedf, atprielccd htdfge eo gypohAgre eo iemsnteo ah enluest, uai kahf egaepnvet cmyoehslsunn r iohnt aei nleatl hd,nia eeetciiecesmtsdplq rh tact dT sa. wlidf hda.o

.nat.Ime oirtaht piatfde st s aeosi tdeihAs mI “n.xsratghotp’ taa”m e ,fetehgieusrghhtfo l veohjeenptt’ hgn t e eosrn."inslsweoholw.ttt uask mn”tiv’ l

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Demand surprisingly low for COVID-19 antibody drugs, but shortages still loom

  1. Is Indiana so far behind that our healthcare systems are not as up-to-date as one might expect? (Remember Lilly is here in Indianapolis!!) Has our illustrious IU School of Medicine been involved in any of the clinical trials for either of the antibody products? Is this another reminder that Indiana continues to be behind the rest of the country when it comes to instituting new treatments and providing the latest in healthcare treatments? Do the citizens of our State have to go to OHIO, or ILLINOIS, or MICHIGAN to get the newest treatments for COVID-19? I guess so!!!

  2. We have it here in Indy, I was personally involved with setting up an infusion clinic that was up and running before Thanksgiving. The opening was on several local stations.

  3. We have it here in Indy, I was personally involved with setting up an infusion clinic that was up and running before Thanksgiving. The opening was on several local stations. And yes, the IU School of Medicine was involved.

  4. Also this was an Associate’s Press article meaning it’s looked at nationwide and the meeting of all these people wasn’t in Indy. Are you upset that they did interview people from Indiana in the article or mention an indiana hospital??

  5. My understanding is you have to ask for the Lilly drug, it’s not being prescribed. Also, have heard it works really well if you have it. I don’t know for a fact you have to request it but if so, I don’t get that. If anyone knows please respond.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In